Healthcare provider profile · identity verified

Bachar Elsaadi, MD

Family Practice · FORT WORTH, TX · NPI 1326421918

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Eliquis	Apixaban	328	45
Atorvastatin Calcium	Atorvastatin Calcium	297	70
Levothyroxine Sodium	Levothyroxine Sodium	291	55
Furosemide	Furosemide	258	60
Gabapentin	Gabapentin	254	61
Pantoprazole Sodium	Pantoprazole Sodium	233	44
Metformin Hcl	Metformin Hcl	214	32
Donepezil Hcl	Donepezil Hcl	212	46
Amlodipine Besylate	Amlodipine Besylate	207	67
Sertraline Hcl	Sertraline Hcl	191	42
Lisinopril	Lisinopril	173	34
Trazodone Hcl	Trazodone Hcl	171	44
Memantine Hcl	Memantine Hcl	163	36
Levetiracetam	Levetiracetam	155	23
Montelukast Sodium	Montelukast Sodium	150	23
Potassium Chloride	Potassium Chloride	148	47
Metoprolol Tartrate	Metoprolol Tartrate	141	37
Tamsulosin Hcl	Tamsulosin Hcl	116	29
Hydralazine Hcl	Hydralazine Hcl	115	34
Mirtazapine	Mirtazapine	113	28
Buspirone Hcl	Buspirone Hcl	106	20
Clopidogrel	Clopidogrel Bisulfate	100	23
Carvedilol	Carvedilol	93	31
Famotidine	Famotidine	86	18
Losartan Potassium	Losartan Potassium	84	24
Omeprazole	Omeprazole	81	22
Duloxetine Hcl	Duloxetine Hcl	75	19
Jardiance	Empagliflozin	73	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	73	23
Spironolactone	Spironolactone	72	20
Metoprolol Succinate	Metoprolol Succinate	70	30
Fluticasone Propionate	Fluticasone Propionate	68	22
Baclofen	Baclofen	67	19
Hydroxyzine Hcl	Hydroxyzine Hcl	60	13
Carbidopa-Levodopa	Carbidopa/Levodopa	58	11
Gemtesa	Vibegron	58	suppressed
Pravastatin Sodium	Pravastatin Sodium	58	13
Divalproex Sodium	Divalproex Sodium	55	16
Humulin R	Insulin Regular, Human	53	suppressed
Januvia	Sitagliptin Phosphate	53	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	52	33
Midodrine Hcl	Midodrine Hcl	52	11
Liothyronine Sodium	Liothyronine Sodium	50	suppressed
Alprazolam	Alprazolam	49	13
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	48	12
Finasteride	Finasteride	48	16
Lidocaine	Lidocaine	48	suppressed
Tizanidine Hcl	Tizanidine Hcl	47	suppressed
Citalopram Hbr	Citalopram Hydrobromide	46	14
Escitalopram Oxalate	Escitalopram Oxalate	46	16
Torsemide	Torsemide	45	14
Metoclopramide Hcl	Metoclopramide Hcl	42	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	40	29
Sodium Chloride	0.9 % Sodium Chloride	40	29
Azithromycin	Azithromycin	37	31
Fosfomycin Tromethamine	Fosfomycin Tromethamine	37	29
Ciprofloxacin Hcl	Ciprofloxacin Hcl	36	31
Ropinirole Hcl	Ropinirole Hcl	36	suppressed
Ondansetron Hcl	Ondansetron Hcl	35	30
Fluoxetine Hcl	Fluoxetine Hcl	34	suppressed
Memantine Hcl Er	Memantine Hcl	34	suppressed
Sucralfate	Sucralfate	34	suppressed
Myrbetriq	Mirabegron	33	suppressed
Divalproex Sodium Er	Divalproex Sodium	31	suppressed
Nuedexta	Dextromethorphan Hbr/Quinidine	31	suppressed
Insulin Aspart Flexpen	Insulin Aspart	30	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	30	suppressed
Budesonide	Budesonide	29	11
Ipratropium Bromide	Ipratropium Bromide	29	20
Lactulose	Lactulose	28	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	28	19
Amiodarone Hcl	Amiodarone Hcl	27	suppressed
Lacosamide	Lacosamide	27	suppressed
Olanzapine	Olanzapine	27	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	27	15
Allopurinol	Allopurinol	26	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	26	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	26	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	26	17
Farxiga	Dapagliflozin Propanediol	25	suppressed
Fenofibrate	Fenofibrate	25	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	25	suppressed
Latanoprost	Latanoprost	25	11
Metolazone	Metolazone	25	suppressed
Aptiom	Eslicarbazepine Acetate	24	suppressed
Diclofenac Sodium	Diclofenac Sodium	24	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	24	11
Lantus	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Glucagon Emergency Kit	Glucagon	23	12
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Ozempic	Semaglutide	23	suppressed
Paliperidone Er	Paliperidone	23	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	22	suppressed
Bupropion Xl	Bupropion Hcl	22	suppressed
Celecoxib	Celecoxib	22	suppressed
Novolin R	Insulin Regular, Human	22	suppressed
Prednisone	Prednisone	22	15
Clonidine Hcl	Clonidine Hcl	21	suppressed
Estradiol	Estradiol	21	suppressed
Hydrocortisone	Hydrocortisone	21	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	21	suppressed
Atenolol	Atenolol	20	suppressed
Carbamazepine	Carbamazepine	20	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	20	suppressed
Folic Acid	Folic Acid	20	suppressed
Nifedipine Er	Nifedipine	20	suppressed
Nystop	Nystatin	20	14
Pregabalin	Pregabalin	20	suppressed
Levofloxacin	Levofloxacin	19	13
Xarelto	Rivaroxaban	19	suppressed
Cefuroxime	Cefuroxime Axetil	18	15
Dicyclomine Hcl	Dicyclomine Hcl	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	18	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	17	17
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	17	suppressed
Mupirocin	Mupirocin	17	12
Ramelteon	Ramelteon	17	suppressed
Albuterol Sulfate	Albuterol Sulfate	16	11
Cephalexin	Cephalexin	16	suppressed
Clonazepam	Clonazepam	16	suppressed
Methotrexate	Methotrexate Sodium	16	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Tresiba Flextouch U-100	Insulin Degludec	16	suppressed
Ammonium Lactate	Ammonium Lactate	15	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	15	suppressed
Bumetanide	Bumetanide	14	suppressed
Cefdinir	Cefdinir	14	12
Meloxicam	Meloxicam	14	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Nystatin	Nystatin	14	suppressed
Primidone	Primidone	14	suppressed
Amantadine	Amantadine Hcl	13	suppressed
Cefixime	Cefixime	13	suppressed
Cilostazol	Cilostazol	13	suppressed
Phenobarbital	Phenobarbital	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Carbamazepine Er	Carbamazepine	12	suppressed
Clindamycin Hcl	Clindamycin Hcl	12	11
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Glipizide	Glipizide	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	11	11
Cartia Xt	Diltiazem Hcl	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Gentamicin Sulfate	Gentamicin Sulfate	11	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	11	suppressed
Insulin Degludec Pen (U-100)	Insulin Degludec	11	suppressed
Levalbuterol Hcl	Levalbuterol Hcl	11	suppressed
Meropenem	Meropenem	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Novolog	Insulin Aspart	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Risperidone	Risperidone	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed
Timolol Maleate	Timolol Maleate	11	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error